Podcast

What You Need to Know About Genomics

Author(s):

Kristie L. Kahl

In this week’s episode, we spoke with a patient and his doctor about genomic testing and how it can change treatment outcomes for patients with cancer.

Cancer is no longer the once thought “one-size-fits-all” approach when it comes to treatment, especially because genomic testing plays such a crucial role for certain patients.

This week, we spoke with Bryce, who was diagnosed with prostate cancer in 2014 and whose cancer journey was changed once he discovered what genomic testing could do for his treatment options. In addition, Dr. Marcia Brose, from the University of Pennsylvania, weighs in on what patients should know about genomic cancer testing.

To learn more, visit testyourcancer.com.

Related Videos
Dr. Kelly Stratton
Reginald Tucker-Seeley, MA, ScM, ScD, an expert on prostate cancer
Alicia Morgans, MD, MPH, an expert on prostate cancer
Reginald Tucker-Seeley, MA, ScM, ScD, an expert on prostate cancer
Rashid K. Sayyid, MD, MSc, an expert on prostate cancer
Rashid K. Sayyid, MD, MSc, an expert on prostate cancer
Related Content
image of breast cancer cells.
October 25th 2024

Jenna Fischer Shares Breast Cancer Details, Los Angeles Dodgers Broadcaster in Remission and More

Alex Biese Ashley Chan
From “The Office” star opening up in a new interview to Charley Steiner revealing his multiple myeloma journey, here is this week’s cancer news.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of a doctor talking with a male patient.
October 23rd 2024

Testosterone Recovery in Prostate Cancer May Depend on ADT Intensity

Ashley Chan
Patients with prostate cancer may differ in time to testosterone recovery, depending on the length of treatment and age, but takes six months on average.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Image of PSA test.
October 21st 2024

Rise in PSA Levels May Predict Treatment Response in Prostate Cancer

Spencer Feldman
The rate at which PSA rises after hormonal therapy for prostate cancer is a key factor in determining the effectiveness of the treatment.
Image of doctor consulting man.
October 18th 2024

Focal Therapy May Reduce Side Effects, Improve Quality of Life in Prostate Cancer

Darlene Dobkowski, MA
With approaches like high intensity focused ultrasound, patients with prostate cancer may experience lower rates of urinary incontinence and erectile dysfunction, an expert said.